Stock News

aTyr Pharma Announces Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of ATYR1923 in Japan
aTyr Pharma Announces Positive Interim Safety Results from Ongoing Phase 1b/2a Clinical Trial of ATYR1923
aTyr Pharma to Present at the Stifel Healthcare Conference 2019
aTyr Pharma Announces Research Collaboration with Boston Children’s Hospital
aTyr Pharma to Participate in September Conferences
First Day of Dealings for UK Cannabis Investment Company
aTyr Pharma to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Leading Immunobiology Researcher Dr. David Briscoe Joins aTyr Pharma as Scientific Advisor
aTyr Pharma to Host Key Opinion Leader Call and Webcast on Sarcoidosis and the Current Treatment Landscape
aTyr Pharma Strengthens Board of Directors with the Appointment of Two New Members
aTyr Pharma Announces Reverse Stock Split to Regain NASDAQ Compliance

As seen on...